# Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis

> **NCT02240953** · NA · UNKNOWN · sponsor: **Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Warfarin + ASA 100 mg + PPI
- **DRUG:** Warfarin + ASA 300 mg + PPI
- **DRUG:** Observational Warfarin

## Key facts

- **NCT ID:** NCT02240953
- **Lead sponsor:** Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-03
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2014-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02240953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02240953, "Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02240953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*